| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2864473 | The American Journal of the Medical Sciences | 2010 | 5 Pages |
Abstract
ASMRI may be used as the initial imaging modality for ruling out CAD in women with low-risk CP because of its very high sensitivity, specificity, and negative predictive value for the detection of ischemia. Further randomized controlled trials comparing ASMRI with established noninvasive nuclear and echocardiographic stress modalities are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stamatios MD, FACC, Matthew MD, Dalton S. MD, Athanasios V. MD, Elisa MD, Emir PhD, John PhD, Arthur E. MD, PhD,